NextCure, Inc. (NXTC) Misses Q3 EPS by 6c

NextCure, Inc. (NASDAQ: NXTC) reported Q3 EPS of ($0.41), $0.06 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.

You May Also Be Interested In

• Cinema United: issues joint letter to state AGs and Paramount
• McEwen Copper seeks $1.6b in equity financing for Los Azules - Bloomberg
• Logansport Financial Corp (LOGN) Declares $.45 Quarterly Dividend; 5% Yield